IP Library Granted Patent US 12,653,893
Granted Patent B2
US 12,653,893 · App. 18/441,882 · Granted Jun 16, 2026

Carbohydrate conjugated RNA agents and process for their preparation

Inventors: Jayaprakash K. Nair (Cambridge, MA); Alexander V. Kel'in (Cambridge, MA); Pachamuthu Kandasamy (Cambridge, MA); Kallanthottathil G. Rajeev (Cambridge, MA); Muthiah Manoharan (Cambridge, MA)
Assignee: ALNYLAM PHARMACEUTICALS, INC.
A61K47/549A61K31/7088C07C231/14C07D207/12C07H1/00C07H15/26C12N15/113C12N2310/351C12N2320/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,653,893
App. No.
18/441,882
Granted
Jun 16, 2026
Kind
B2
Abstract

This disclosure relates to an improved process for the preparation of carbohydrate conjugates. The disclosure also relates to carbohydrate conjugated iRNA agents comprising these carbohydrate conjugates, which have improved purity and are advantageous for the in vivo delivery of the iRNA agents.

Claims (49)

1 . A compound of formula (VIII):

wherein A is a C 6 -C 14 alkylene linker; each R is, independently, an acid protecting group; and R x is an acid protecting group.

2 . The compound of claim 1 , wherein A is a C 8 -C 12 alkylene linker.

3 . The compound of claim 1 , wherein A is —(CH 2 ) 10 —.

4 . The compound of claim 1 , wherein each R is, independently, substituted or unsubstituted alkyl.

5 . The compound of claim 1 , wherein each R is t-butyl.

6 . The compound of claim 1 , wherein R x is substituted or unsubstituted alkyl.

7 . The compound of claim 1 , wherein R x is methyl.

8 . The compound of claim 1 , wherein R x is different from all the R groups.

9 . The compound of claim 1 that is:

10 . A compound of formula (II):

and a counterion, wherein Z is an acid protecting group; n is 0-20; and each occurrence of r and s is independently 1-7.

11 . The compound of claim 10 , wherein the counterion is CF 3 SO 3 −.

12 . The compound of claim 10 , wherein n is 0-15.

13 . The compound of claim 10 , wherein n is 4-15.

14 . The compound of claim 10 , wherein n is 7.

15 . The compound of claim 10 , wherein r is 1.

16 . The compound of claim 10 , wherein s is 1.

17 . The compound of claim 10 , wherein Z is alkyl, substituted alkyl, aryl, or substituted aryl.

18 . The compound of claim 11 , wherein Z is methyl, ethyl, sec-butyl, tert-butyl, chloromethyl, bromomethyl, 2-iodoethyl, 2-fluoropropyl, phenyl, 2-bromophenyl, 4-4 chlorophenyl, 4-methoxyphenyl, p-tolyl, o-tolyl, 4-benzyloxyphenyl, 3-carbamoylphenyl, 4-chloro-3-cyanophenyl, 4-methoxy-2-tolyl, 4- trifluoromethylphenyl, benzyl, 4-methoxybenzyl, 4-iodobenzyl, 3-methanesulfonamidobenzyl, 3-nitrobenzyl, 3-chloro-4-benzyloxybenzyl, 2-ethylbenzyl, phenoxymethyl, 4- bromophenoxymethyl, 2-methoxyphenoxymethyl, 4-tolyloxymethyl, 4-chlorophenoxymethyl, 4-carbamoylphenoxymethyl, or 3-chloro-4-ethoxyphenoxymethyl.

19 . The compound of claim 10 that is:

20 . A compound of the formula (XII):

wherein Z is an acid protecting group;

n is 0-20;

each occurrence of r and s is independently 1-7; and

P is an amino protecting group.

21 . The compound of claim 20 , wherein n is 0-15.

22 . The compound of claim 20 , wherein n is 4-15.

23 . The compound of claim 20 , wherein n is 7.

24 . The compound of claim 20 , wherein r is 1.

25 . The compound of claim 20 , wherein s is 1.

26 . The compound of claim 20 , wherein P is Boc.

27 . The compound of claim 20 , wherein Z is alkyl, substituted alkyl, aryl, or substituted aryl.

28 . The compound of claim 20 , wherein Z is methyl, ethyl, sec-butyl, tert-butyl, chloromethyl, bromomethyl, 2-iodoethyl, 2-fluoropropyl, phenyl, 2-bromophenyl, 4-chlorophenyl, 4-methoxyphenyl, p-tolyl, o-tolyl, 4-benzyloxyphenyl, 3-carbamoylphenyl, 4-chloro-3-cyanophenyl, 4-methoxy-2-tolyl, 4- trifluoromethylphenyl, benzyl, 4-methoxybenzyl, 4-iodobenzyl, 3-methanesulfonamidobenzyl, 3-nitrobenzyl, 3-chloro-4-benzyloxybenzyl, 2-ethylbenzyl, phenoxymethyl, 4- bromophenoxymethyl, 2-methoxyphenoxymethyl, 4-tolyloxymethyl, 4-chlorophenoxymethyl, 4-carbamoylphenoxymethyl, or 3-chloro-4-ethoxyphenoxymethyl.

29 . The compound of claim 20 that is

30 . A compound of formula (IV):

wherein Z is an acid protecting group;

n is 0-20;

q, r, and s are independently 1-7;

X is a hydroxy protecting group or hydrogen; and

Y is an amine protecting group.

31 . The compound of claim 30 , wherein all occurrences of X are the same, all occurrences of Y are the same, all occurrences of q are the same, all occurrences of r are the same, and all occurrences of s are the same.

32 . The compound of claim 30 , wherein X is benzyl (Bz) or acetyl (Ac).

33 . The compound of claim 30 , wherein Y is acetyl.

34 . The compound of claim 30 , wherein X is benzyl (Bz) or acetyl (Ac); and Y is acetyl.

35 . The compound of claim 30 , wherein n is 7, q is 1, r is 1, and s is 1.

36 . The compound of claim 30 , wherein n is 6, q is 1, r is 1, and s is 1.

37 . The compound of claim 30 , that is:

38 . A compound that is:

Assignments (2)
SECURITY INTEREST Recorded Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2024
From: NAIR, JAYAPRAKASH K; KELIN, ALEXANDER V; KANDASAMY, PACHAMUTHU; RAJEEV, KALLANTHOTTATHIL G; MANOHARAN, MUTHIAH
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 067755/0689 →